LACHOWICZ, JOANNA IZABELA
 Distribuzione geografica
Continente #
EU - Europa 147.991
NA - Nord America 5.337
AS - Asia 961
AF - Africa 13
OC - Oceania 12
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 154.324
Nazione #
IT - Italia 146.680
US - Stati Uniti d'America 5.281
CN - Cina 533
SE - Svezia 476
UA - Ucraina 351
SG - Singapore 155
DE - Germania 123
GB - Regno Unito 122
FI - Finlandia 110
VN - Vietnam 60
SA - Arabia Saudita 54
CA - Canada 42
KR - Corea 40
IN - India 36
FR - Francia 32
IR - Iran 19
BE - Belgio 14
ES - Italia 14
IE - Irlanda 13
JP - Giappone 12
AU - Australia 11
NL - Olanda 11
PK - Pakistan 10
MX - Messico 9
RO - Romania 9
RU - Federazione Russa 9
TR - Turchia 9
EG - Egitto 8
HK - Hong Kong 8
GR - Grecia 7
BR - Brasile 6
PL - Polonia 6
CH - Svizzera 4
IL - Israele 4
PA - Panama 4
TW - Taiwan 4
DK - Danimarca 3
LT - Lituania 3
QA - Qatar 3
EU - Europa 2
ID - Indonesia 2
MN - Mongolia 2
PT - Portogallo 2
TH - Thailandia 2
BB - Barbados 1
BD - Bangladesh 1
CI - Costa d'Avorio 1
CL - Cile 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
JO - Giordania 1
MA - Marocco 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 154.324
Città #
Cagliari 143.770
Uta 2.456
Fairfield 708
Ashburn 670
Woodbridge 489
Nyköping 367
Chandler 334
Houston 308
Boardman 297
Wilmington 267
Seattle 261
Ann Arbor 254
Cambridge 230
Jacksonville 177
Dearborn 164
Santa Clara 103
Singapore 84
Boston 71
New York 71
Shanghai 70
Nanjing 69
Beijing 64
Helsinki 63
Dong Ket 60
Escalaplano 58
San Diego 52
Redwood City 48
Sassari 32
Guangzhou 30
Nanchang 29
London 28
Seoul 28
Mountain View 25
Shenyang 22
Los Angeles 20
Rome 19
Toronto 17
Changsha 16
Ottawa 16
Tianjin 16
Hebei 15
Milan 14
Norwalk 14
Atlanta 13
Hefei 13
Jiaxing 13
Jinan 12
Orange 12
Brussels 11
Zhengzhou 11
Pune 9
Dublin 8
Falls Church 8
Kilburn 7
Spin 7
Washington 7
Auburn Hills 6
Calcinelli 6
Chicago 6
Hangzhou 6
Iglesias 6
Munich 6
Ningbo 6
Phoenix 6
Shenzhen 6
Verona 6
Chengdu 5
Medina 5
Mumbai 5
San Mateo 5
Acerra 4
Cesena 4
Derio 4
Fuzhou 4
Genoa 4
Hong Kong 4
Kunming 4
Lanzo Torinese 4
Melbourne 4
Moscow 4
Nurallào 4
Pohang 4
Pueblo Nuevo 4
Redmond 4
Taipei 4
Tehran 4
Vancouver 4
Villa Castelli 4
Wuhan 4
Amsterdam 3
Delhi 3
Doha 3
Gif-sur-yvette 3
Harbin 3
Harrow 3
Islamabad 3
Islington 3
Jeddah 3
Kharagpur 3
Makkah 3
Totale 152.226
Nome #
Iron Chelation for Iron Overload in Thalassemia 5.644
A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity 3.753
Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one 3.537
Complex formation equilibria of Cu2 + and Zn2 + with Irbesartan and Losartan 3.452
para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite 3.414
Multiple Sclerosis and environmental factors. 3.192
Adsorption of Cu2+ and Zn2+ on SBA-15 mesoporous silica functionalized with triethylenetetramine chelating agent 3.123
Gold - Old drug with new potentials 3.118
Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic 2.842
Searching for new aluminium chelating agents: a family of hydroxypyrone ligands 2.694
Metal coordination of thymosin β4: Chemistry and possible implications 2.693
Salicylamide derivatives for iron and aluminium sequestration. From synthesis to complexation studies 2.654
Assessment, validation and application to real samples of an RP-HPLC method for the determination of Guayulins A, B, C and D in Guayule Shrub 2.570
Thymosin b4 cytoplasmic/nuclear translocation as a new marker of cellular stress. A Caco2 case study 2.480
null 2.477
Looking at new ligands for chelation therapy 2.439
Geoepidemiology of Multiple Sclerosis: the environmental factors. 2.404
Depleted uranium and human health 2.355
A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies 2.327
Multi analytical technique study of human bones from an archaeological discovery 2.310
A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays 2.303
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III) 2.200
Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives 2.139
Metal self-assembly mimosine peptides with enhanced antimicrobial activity: towards a new generation of multitasking chelating agentsts 2.117
Do anti-diabetic drugs act as copper ligands? 2.109
New insights into the protogenic and spectroscopic properties of commercial tannic acid: the role of gallic acid impurities 2.104
Toxicity of nanoparticles: etiology and mechanisms 2.093
Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators 1.971
Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+ 1.966
Tungsten or wolfram: Friend or foe? 1.946
Chelation therapy for metal intoxication. Comments from a thermodynamic view point 1.905
Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds 1.888
Kill or cure: Misuse of chelation therapy for human diseases 1.853
The meaning of aluminium exposure on human health and aluminium-related diseases 1.837
Substituent effects on ionization constants as a predictive tool of coordinating ability 1.818
A new hydroxypyrone powerful chelator. From synthesis to AlIII, FeIII, CuII and ZnII complex formation equilibria, and structural characterization 1.817
Silver coordination compounds: A new horizon in medicine 1.788
Alarming use of chelation therapy 1.770
Chemical features of in use and in progress chelators for iron overload 1.763
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions 1.756
Iron III and aluminium III complexes with substituted salicyl-aldehydes and salicylic acids 1.742
State of art in chelating agents for the clinical treatment of metal poisoning 1.728
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl3-({[(5-hydroxy-4-oxo-4H-pyran-2-yl)methoxy] carbonyl}amino) propanoate. Synthesis and its complex formation study 1.721
Oxovanadium(IV) coordination compounds with kojic acid derivatives in aqueous solution 1.720
An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions 1.715
Improving Metal Adsorption on Triethylenetetramine (TETA) Functionalized SBA-15 Mesoporous Silica Using Potentiometry, EPR and ssNMR 1.707
Comparison of selectivity of a family of chelating agents for trivalent (Al3+, Fe3+) and bivalent (Cu2+, Zn2+) metal ions 1.702
Hydroxypyrones, an intriguing family of chelating agents for Fe(III) and Al(III) 1.679
The Best Peptidomimetic Strategies to Undercover Antibacterial Peptides 1.678
Biomonitoring of toxic element exposure by ICP-AES and ICP-MS analysis 1.677
5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one molecule as an intriguing tool in coordination and enzymatic studies 1.673
Noble metals in medicine: Latest advances 1.650
Unusual PLS application for Pd(ii) sensing in extremely acidic solutions 1.647
A family of hydroxypyrone ligands designed and synthesized for iron chelators 1.622
Competition between Cd(II) and other divalent transition metal ions during complex formation with amino acids, peptides, and chelating agents 1.544
Losartan: a low water soluble oral drug with Cu(II) and Zn(II) coordination properties 1.535
Synthesis and Mass Spectrometry Analysis of Mimosine-Containing Peptides 1.446
Toxicity of nanoparticles 1.325
null 1.188
Warns against unapproved ‘chelation therapy’ 1.119
Living with the enemy: from protein-misfolding pathologies we know, to those we want to know 1.104
Metal ions in the pathogenesis of Alzheimer’s disease: an open field 1.069
Zinc as a drug for Wilson’s disease, non-alcoholic liver disease and covid-19-related liver injury 999
null 941
Grafting of the 2,8-dithia-5-aza-2,6-pyridinophane macrocycle on SBA-15 mesoporous silica for the removal of Cu2+ and Cd2+ ions from aqueous solutions: synthesis, adsorption, and complex stability studies 915
Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites 874
Nutritional iron deficiency: the role of oral iron supplementation 860
Different approaches to the study of chelating agents for iron and aluminium overload pathologies 852
null 845
Undercover Toxic Ménage à Trois of Amylin, Copper (II) and Metformin in Human Embryonic Kidney Cells 832
Kojic Acid Derivatives as Iron (III) and Aluminium (III) Chelators 821
Thymosin β4 Is an Endogenous Iron Chelator and Molecular Switcher of Ferroptosis 782
Manganese and cobalt binding in a multi-histidinic fragment 764
Kojic acid derivatives as double face ligands for metal and phosphate ions. 759
Metal complex formation and anticancer activity of cu(I) and cu(ii) complexes with metformin 742
Exploring cell surface markers and cell-cell interactions of human breast milk stem cells 713
Study of the DNA binding mechanism and in vitro activity against cancer cells of iron(III) and aluminium(III) kojic acid derivative complexes 706
Nickel Binding Sites in Histone Proteins: Spectroscopic and Structural Characterization 669
Metals and metal-nanoparticles in human pathologies: From exposure to therapy 666
Kojic Acid derivate as a selective inhibitor of mitosis in colorectal and glioblastoma cancer cells 640
Fluorescent squaramide ligands for cellular imaging and their encapsulation in cubosomes 639
Potentiometric, spectrophotometric and computer studies with aspergillic acid and its derivatives 631
Generalized scleroderma-like induration associated with D-penicillamine elastosis perforans serpiginosa in Wilson's disease 527
Interaction between aspergillic acid and iron(III). A potentiometric, UV-Vis, 1H-NMR and quantum chemical study 480
Nuovi derivati dell’acido kojico come chelanti per il ferro(III). 441
NMR as a “gold standard” method in drug design and discovery 433
Effect of substituents on complex stability aimed at designing new iron(III) and aluminum(III) chelators 414
Cell starvation increases uptake of extracellular Thymosin β4 and its complexes with calcium 402
Toward the renal vesicle: Ultrastructural investigation of the cap mesenchyme splitting process in the developing kidney 401
What doesn't kill you makes you stronger: Future applications of amyloid aggregates in biomedicine 401
Cooking Particulate Matter: A Systematic Review on Nanoparticle Exposure in the Indoor Cooking Environment 364
Human breast milk cells are positive for the pioneer transcription factor ISL1 361
The interaction of aluminum with catecholamine-based neurotransmitters: Can the formation of these species be considered a potential risk factor for neurodegenerative diseases? 304
In silico design of mimosine containing peptides as new efficient chelators of aluminum 304
You are what you eat: Application of Metabolomics Approaches to Advance Nutrition Research 292
A pilot study of occupational exposure to ultrafine particles during 3D printing in research laboratories 265
Towards the functional high-resolution coordination chemistry of blood plasma human serum albumin 264
Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations 218
Kojic acid derivatives as aluminum(III) and iron(III) chelators 143
Fluxomics - New Metabolomics Approaches to Monitor Metabolic Pathways 143
Totale 154.419
Categoria #
all - tutte 185.807
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 185.807


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014.814 0 0 0 0 0 7.315 3.811 700 495 793 547 1.153
2020/202140.103 1.225 1.635 1.826 11.611 7.787 4.253 2.833 2.381 1.022 2.220 1.995 1.315
2021/20227.745 972 731 398 535 609 618 475 271 544 755 913 924
2022/202310.333 794 1.170 1.265 886 852 1.178 597 948 686 632 785 540
2023/202411.762 588 468 435 622 1.149 1.846 1.925 1.130 521 796 1.088 1.194
2024/202520.261 5.936 6.383 3.084 2.268 1.316 1.274 0 0 0 0 0 0
Totale 154.723